Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Aug 8, 2017 · 10-Q · 39 days after period end · 0001493152-17-008676
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | $1.02M | -$4.70M | -$890.80K | -$427.57K |
| EPS Diluted | $0.25 | -$0.13 | -$0.03 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 8, 2017 · 39 d after period end
